Vivani Medical VANI
NASDAQ VANI
$1.15 +0.02 (+2.22%)
At close: Nov 10, 2026 · 4:00 PM EST

Vivani Medical (VANI) Restructuring Costs (2018 - 2020)

Updated

Vivani Medical (VANI) reported Restructuring Costs of $2.23 million for FY2020, down 33.6% from $3.36 million in FY2019.

Analysis

Vivani Medical (VANI) Restructuring Costs (2018 - 2020) Analysis & Trends

  • According to Business Quant data, Restructuring Costs came in at $3.36 million in FY2019 (+504.9%) and $555,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Vivani Medical 97.98 Mn 39.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 848,000.00
Mar 31, 2020 1.38 Mn
Dec 31, 2019 60,000.00
Jun 30, 2019 873,000.00
Mar 31, 2019 2.42 Mn
Dec 31, 2018 600,000.00
API Access

Vivani Medical Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=VANI&period=max&api_key=YOUR_API_KEY